ARCHIVES

Skipper’s Impact: Drugs Curing 40,000 a Year

This article is from The Cancer Letter archive.

Vol. 07 No. 13 | March 27, 1981

Download PDF Visit The Full Archive

Related Articles

Who Makes This Drug? Secretive Contract Manufacturing Agreements Complicate Solutions to Shortages of Generics

January 3, 2014

Tamoxifin Benefits Outweigh Risks, NSABP Study Finds

March 23, 1994

Obama Signs Bill Giving FDA Authority Over Tobacco Products

June 26, 2009

Oncology Practice Group Leaves Allegheny For Former Rival UPCI; Will NSABP Follow?

June 30, 2000

NCI Has No Intention Of “Dismembering” Groups, Official Says

June 12, 1998

NTP Board Okays Contract Concepts

July 10, 1981